Login / Signup

Impact on functionality of the paliperidone palmitate three-month formulation in patients with a recent diagnosis of schizophrenia: a real-world observational prospective study.

Maria Paz Garcia-PortillaAdolfo Benito RuizFelisa Gómez RobinaMarta García DoradoPaola María López Rengel
Published in: Expert opinion on pharmacotherapy (2022)
Early introduction of PP3M in the course of schizophrenia is associated with a meaningful benefit in social functioning and at least maintains clinical stability.
Keyphrases
  • bipolar disorder
  • healthcare
  • mental health
  • drug delivery
  • cross sectional